ChronoScale targets $1 billion run rate by Q3 2027 after AI contract expansion
ChronoScale expanded an AI infrastructure contract with an existing customer and signed a separate agreement with a new customer. Together with its current contracts and deployment plans, the company said the agreements provide for $1 billion in annualized revenue run rate by calendar Q3 2027. ChronoScale also completed the divestiture of its Ekso Bionics business unit to concentrate on accelerated compute and AI infrastructure.
Why it matters
The target depends on ChronoScale deploying and commissioning capacity on time, securing power and equipment, and obtaining capital on acceptable terms. The completed divestiture concentrates the company’s operations and capital allocation on its AI infrastructure business.
Key facts
- 1ChronoScale announced an extension with an existing AI infrastructure customer and a separate agreement with a new customer. globenewswire.com
- 2The company said its contracts and deployment schedule provide for $1 billion in annualized revenue run rate by calendar Q3 2027. globenewswire.com
- 3ChronoScale completed the previously disclosed sale of its Ekso Bionics business unit. globenewswire.com
- 4The company said the revenue target is subject to infrastructure deployment, power and equipment availability, and access to capital on acceptable terms. globenewswire.com
Open questions
- ChronoScale did not identify the counterparties to the newly announced agreements.
- Financial terms of the Ekso Bionics business-unit sale were not disclosed.
Summary written by AlphAI from 8 of 8 sources. Not investment advice. Figures are as stated by the linked sources.